Zevra Therapeutics Inc Share Price

NASDAQ: ZVRA

Small Cap

$7.21

-0.54

(-6.90%)

as on September 16, 2025 at 1:29 am IST

$₹

Zevra Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$7.22
Day's Price Range
$7.74
$7.21
-0.14%
Downside
7.35%
Upside
52 Week's Low
52 Week's High
$6.19
52-Week Price Range
$13.16
$7.21
14.15%
Downside
82.52%
Upside

Zevra Therapeutics Inc share price movements today

Previous Close: $7.75
Open: $7.73
Volume: 1.5M
Day's Low - High: $7.22 - $7.74
52 Week Low - High: $6.19 - $13.16

Zevra Therapeutics Inc Historical Returns

1 Month Return: -17.82 %
3 Month Return: -15.12 %
1 Year Return: -1.27 %
3 Year Return: 0 %
5 Year Return: 0 %

Zevra Therapeutics Inc Stock Fundamentals & Key Indicators

Check Zevra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$435.0M

EPS (TTM)

1.22

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.91

Industry PE ratio

P/B Ratio

PEG Ratio

10.6667

EBITDA

-53.8M

Revenue (TTM)

62.0M

Profit Margin

4.26%

Return On Equity TTM

38426500.00%

Zevra Therapeutics Inc Stock Valuation

Track how Zevra Therapeutics Inc P/E has moved over time to understand its valuation trends.

Zevra Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-5.91x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -5.91x

Zevra Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zevra Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Zevra Therapeutics Inc	BUY	$435.0M	NA	-5.91	4.26%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Zevra Therapeutics Inc Stock including INR - Dollar returns

The Zevra Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zevra Therapeutics Inc investment value today

Current value as on today

₹96,833

Returns

₹3,167

(-3.17%)

Returns from Zevra Therapeutics Inc Stock

₹8,153 (-8.15%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Zevra Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Zevra Therapeutics Inc. Average target price of $23.22

Zevra Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Zevra Therapeutics Inc.

What analysts predicted

68.95%UPSIDE

Target Price

$23.22

Current Price

$7.21

Analyzed by

12 Analysts

Target

$23.22

Zevra Therapeutics Inc target price $23.22, a slight upside of 68.95% compared to current price of $7.21. According to 12 analysts rating.

Zevra Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Zevra Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-38% versus previous 30 day period

Zevra Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	2	8	2	3	4	3	12	20	25
Gross Profit	2	2	7	2	0	0	1	10	19	13
Operating Income	9	-12	-6	-15	-20	-23	-27	-15	-5	-71
EBITDA	-8	-12	-4	-13	-14	-16	-29	-16	1	-71
Interest Expense	0	0	0	0	0	2	1	2	1	2
Depreciation	0	0	0	0	1	1	1	1	1	1
Income Before Tax	-9	-11	-5	-10	-16	-19	-33	-20	-1	76
Income Tax Expense	0	0	0	0	0	0	-	15	-1	2
Net Income	-9	-11	-5	-10	-16	-19	-33	-35	-3	74
Net Profit Margin	-389.00%	-408.72%	-60.02%	-358.10%	-485.31%	-447.85%	-899.19%	-296.76%	-15.19%	288.66%

Zevra Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	12	13	28	10	27	23
Gross Profit	9	11	26	9	24	16
Operating Income	-20	-5	7	-42	-49	-87
EBITDA	-17	-5	-7	-25	-43	-76
Interest Expense	6	7	0	0	1	7
Depreciation	0	0	0	0	0	6
Income Before Tax	-24	-12	-8	-26	-46	-90
Income Tax Expense	0	0	0	0	-	15
Net Income	-24	-12	-8	-26	-46	-105
Net Profit Margin	-191.00%	-96.03%	-29.86%	-263.48%	-167.69%	-446.85%

Zevra Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-14	-15	-16	-19	-33	-35	-3	74
Operating Cash Flow	-8	-4	-16	-16	-19	-18	-16	-8	-3
Investing Cash Flow	34	-44	-	14	0	-31	-5	10	11
Financing Cash Flow	0	26	5	1	15	64	0	1	1
Change in Cash	26	-22	0	0	-3	14	-20	3	10

Zevra Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-43	-56	-24	-12	-8	-41	-46	-105
Operating Cash Flow	-29	-33	-54	-23	-1	10	-18	-33	-69
Investing Cash Flow	-46	27	33	3	0	-15	-36	-17	-22
Financing Cash Flow	61	0	28	4	2	113	8	28	82
Change in Cash	-15	-5	7	-15	0	108	-46	-22	-9

Insights on Zevra Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -35.73M → 74.70M (in $), with an average increase of 578.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 3.69M → 25.88M (in $), with an average increase of 43.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 76.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 110.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ZVRA stock has moved down by -7.0%

About Zevra Therapeutics Inc

kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.

Organisation	Zevra Therapeutics Inc
Headquarters	1180 Celebration Boulevard, Celebration, FL, United States, 34747
CEO	Mr. Neil F. McFarlane
E-voting on shares	Click here to vote

Key Management of Zevra Therapeutics Inc

Name	Title
Mr. R. LaDuane Clifton CPA	CFO & Treasurer
Mr. Rahsaan W. Thompson J.D.	Chief Legal Officer, Secretary & Compliance Officer
Ms. Alison Peters	Chief People Officer
Dr. Christopher M. Lauderback Ph.D.	Senior Vice President of Manufacturing
Mr. Joshua M. Schafer M.B.A.	Chief Commercial Officer
Mr. Gerald J. Orehostky	Senior Vice President of Regulatory Affairs & Quality
Mr. Neil F. McFarlane	President, CEO & Director
Ms. Nichol L. Ochsner	Vice President of Investor Relations & Corporate Communications
Ms. Tanya Hayden	Senior VP & Chief of Staff
Dr. Adrian Quartel FFPM, M.D.	Chief Medical Officer

FAQs

What is Zevra Therapeutics Inc share price today?

Zevra Therapeutics Inc share price today is $7.21 as on September 16, 2025 at 1:29 am IST at the close of the market. Zevra Therapeutics Inc share today touched a day high of $7.74 and a low of $7.22.

What is the 52 week high and 52 week low for Zevra Therapeutics Inc share?

Zevra Therapeutics Inc share touched a 52 week high of $13.16 on July 15, 2025 and a 52 week low of $6.19 on April 9, 2025. Zevra Therapeutics Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $7.21,which is 45.21% down from its 52 week high and 16.48% up from its 52 week low.

What is Zevra Therapeutics Inc's market capitalisation today?

Zevra Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Zevra Therapeutics Inc Stock (ZVRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zevra Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zevra Therapeutics Inc Shares that will get you 0.2080 shares as per Zevra Therapeutics Inc share price of $7.21 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Zevra Therapeutics Inc Stock (ZVRA) from India?

Indian investors can start investing in Zevra Therapeutics Inc (ZVRA) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 5:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Zevra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 5:41 am IST). Based on Zevra Therapeutics Inc share’s latest price of $7.21 as on September 16, 2025 at 1:29 am IST, you will get 1.3870 shares of Zevra Therapeutics Inc. Learn more about fractional shares .